MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-20-0006938
Arlak Biotech Private Limited - healthcare in Zirakpur, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹31.65 Cr
▲ 22% YoY
Net profit · FY 2025
₹1.08 Cr
Net margin 3.4%
EBITDA · FY 2025
₹1.86 Cr
EBITDA margin 5.9%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
₹3.9 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
2
Provident fund records
About Arlak Biotech Private Limited
Data last updated:
Arlak Biotech Private Limited is a private limited company based in Zirakpur, Punjab, India. It operates in the pharmaceutical distribution segment of the healthcare sector. It was incorporated on 27 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2007PTC031093. Its GSTIN is 03AAGCA5095C1Z1 (Punjab).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Jyoti and Dhiraj Kalra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO No.6 Wadhawa Nagar Near Sunpark Hotel Dhakoli, Zirakpur, Punjab, India – 140603.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.65 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.08 Cr (net margin 3.4%) and EBITDA of ₹1.86 Cr (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Arlak Biotech. As per MCA filings, the company has open charges of ₹3.9 Cr on record. Court records list 4 cases involving the company, including 3 filed against it; 3 cases are pending.
Arlak Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0006938). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arlakbiotech.com.
Company Details of Arlak Biotech Private Limited
CIN U24232PB2007PTC031093
Registration Number 031093
Incorporation Date 27 April 2007
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PB-20-0006938
Recognitions & Rankings of Arlak Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Apps
- Registered AddressSCO No.6 Wadhawa Nagar Near Sunpark Hotel Dhakoli, Zirakpur, Punjab, India – 140603
- IndustryHealthcare, Pharmaceutical Distribution
Comprehensive company report
Arlak Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Arlak Biotech Private Limited
Arlak Biotech operates one associated brand: Arlak Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical products and franchise opportunities nationwide. | arlakbiotech.com |
Business Activity of Arlak Biotech Private Limited
The main business activity of Arlak Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arlak Biotech Private Limited FY 2025 filings available
Arlak Biotech Private Limited reported revenue of ₹31.65 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹31.65 Cr ▲ 22%
Net profit · FY 2025
₹1.08 Cr margin 3.4%
EBITDA · FY 2025
₹1.86 Cr margin 5.9%
Compounded Annual Growth Rate (CAGR) of Arlak Biotech Private Limited
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 5%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 115%
3 years · compounded
▲ 42%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 22% growth in the latest year. EBITDA rose 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Arlak Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.08 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Arlak Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Arlak Biotech are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Arlak Biotech Private Limited
Arlak Biotech has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti | Director | 27 Apr 2007 | 19 Years 5 Months | Current |
| Dhiraj Kalra Also directs: Magicdose Private Limited | Director | 27 Apr 2007 | 19 Years 5 Months | Current |
| Umesh Kalra Also directs: Gallberry Formulations Private Limited, Magicdose Private Limited, Medvalue Private Limited and 5 more | Director | 27 Apr 2007 | 19 Years 5 Months | Current |
Peer Comparison of Arlak Biotech Private Limited
Arlak Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shubh Medicorp (India) Private Limited | ₹32.12 Cr (FY 2024) | •••• | •••• | -24.0% | •••• | Pune, Maharashtra, India |
| Push Logistics and Warehousing Private Limited | ₹32.11 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Thistle Healthcare India Private Limited | ₹31.89 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Kozhikode, Kerala, India |
| GSK Pharma India Private Limited | ₹31.87 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Mumbai, Maharashtra, India |
| Nirvvan Lifescience Private Limited | ₹31.76 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Mumbai, Maharashtra, India |
| Arlak Biotech Private Limited this company | ₹31.65 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Zirakpur, Punjab, India |
| Rare Metabolics Life-Sciences Private Limited | ₹31.63 Cr (FY 2024) | •••• | •••• | 443.0% | •••• | New Delhi, Delhi, India |
| Rusan Health Care Private Limited | ₹31.6 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Gpho Private Limited | ₹31.56 Cr (FY 2025) | •••• | •••• | 140.0% | •••• | Hyderabad, Telangana, India |
| Dadha Pharma Private Limited | ₹31.45 Cr (FY 2022) | •••• | •••• | 248.0% | •••• | Chennai, Tamil Nadu, India |
| Guninaa Pharmaceuticals Private Limited | ₹31.33 Cr (FY 2025) | •••• | •••• | 406.0% | •••• | Bareilly, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Arlak Biotech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Arlak Biotech Private Limited
Arlak Biotech Private Limited is audited by HARISH DHIMAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HARISH DHIMAN & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Arlak Biotech Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Arlak Biotech Private Limited
Open charges
₹3.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2015 | Others | ₹3.9 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Arlak Biotech Private Limited
Arlak Biotech Private Limited has 4 court cases on record: 3 filed against it, 1 where it is another party. 3 cases are pending and 1 is disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Total cases
4
Filed against the company
3
Pending
3
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
| District courts | 2 | 1 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Modi-Mundipharma Private Limited | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Yogi Ayurvedic Products Private Limited | Pending |
| District court, Vellore, Tamil Nadu | Criminal case | Company is another party | Pending |
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed against the company by Astalon Pharmaceuticals | Disposed |
Premium access
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Arlak Biotech Private Limited
Arlak Biotech Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 35 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| QSD Formulations Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Gnosis Pharmaceuticals Private Limited | •••• | •••• | •••• |
| C.B. Healthcare | •••• | •••• | •••• |
| Amster Labs | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Arlak Biotech Private Limited
Arlak Biotech Private Limited has a workforce of 2 employees as of Oct 22, 2024.
Employee count
2
Active EPFO establishments
1
Employee growth
-60%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Arlak Biotech Private Limited
Arlak Biotech Private Limited has 3 board changes on record since 2007: 3 appointments. The latest: Dhiraj Kalra was appointed as Director on 27 Apr 2007.
Charges
A charge with Others of Rs. 390.00 Lakh registered on 22 Dec 2015 with Charge ID 10609563 was modified on 30 Nov 2025.
AGM
Arlak Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Arlak Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 390.00 Lakh with Charge ID 10609563 was registered on 22 Dec 2015.
Appointed
Dhiraj Kalra was appointed as Director.
Appointed
Jyoti was appointed as Director.
Appointed
Umesh Kalra was appointed as Director.
Incorporation
27 Apr 2007
Arlak Biotech Private Limited was registered on 27 Apr 2007 with Roc Chandigarh & aged 19 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Arlak Biotech Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arlak Biotech Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arlak Biotech Private Limited
Arlak Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAGCA5095C1Z1 | Punjab | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arlak Biotech Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Arlak Biotech Private Limited
Frequently Asked Questions about Arlak Biotech Private Limited
Arlak Biotech is an active private limited company based in Zirakpur, Punjab, India. The company works in pharmaceutical distribution, within the healthcare industry. It was incorporated on 27 April 2007 (19+ years old) and is registered under CIN U24232PB2007PTC031093.
Arlak Biotech reported revenue of ₹31.65 Cr for FY 2025 (up 22% YoY).
Arlak Biotech has 3 current directors:
- Jyoti - Director
- Dhiraj Kalra - Director
- Umesh Kalra - Director
Arlak Biotech reported a net profit of ₹1.08 Cr (net margin 3.4%) and EBITDA of ₹1.86 Cr (EBITDA margin 5.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Arlak Biotech is 5% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Arlak Biotech is 03AAGCA5095C1Z1, registered in Punjab.
The CIN (Corporate Identification Number) of Arlak Biotech is U24232PB2007PTC031093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arlak Biotech has 4 court cases on record: 3 filed against it. 3 are pending. Most are in the high courts.
Arlak Biotech was incorporated on 27 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Arlak Biotech by revenue are Shubh Medicorp (India) Private Limited, Push Logistics and Warehousing Private Limited, Thistle Healthcare India Private Limited, GSK Pharma India Private Limited, Nirvvan Lifescience Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Dhiraj Kalra was appointed as Director on 27 Apr 2007. Jyoti was appointed as Director on 27 Apr 2007. Umesh Kalra was appointed as Director on 27 Apr 2007.
Yes, Arlak Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-PB-20-0006938).